RE:RE:RE:RE:RE:RE:RE:RE:RE:A few thoughtsHi narmac.
I agree in the sense that Zenith has no value to me because it lacks liquidity. I've asked Zenith twice about when they are going to create liquidity either in the form of IPOs or creating an internal market and their answers were non-commital...dissappointing.
However, there are BPs and pharma based venture capital companies out there that see the future of epigenetics and the reported results achieved by Zenith. They will be putting a value on it just like large software companies valuing new apps that have never made a buck.
From a Zenith POV they know the market potential with each of their platforms and thus can establish some very crude sense of potential value. They better be doing this because without it they have no negotiating platform. They can and should be looking at other related IPOs and CVRs as well to establish a perspective on value.
At the end of the day the share price will be established by the market if they go public or by a private buyer.
Yes, it's current value is $0 (P/E ratio is infinite) on the books.
What does concern me is what Sanfran has pointed out with insiders bringing in funding at $1.00/share. Of course the funding is needed to keep these businesses moving and so they have the edge but I think they are getting share on the cheap. The current stock price is not reflective of the huge potential (that is if there is any probability of RVX being successful).
My birthday is on July 1st. I can tell you I was not smiling at my 2013 birthday (although I can only blame myself) BUT I do hope I'll be smiling this year. So fair I have hope but big doubts.
Cheers
Toinv